Toggle navigation
Home
Search
Services
Blog
Contact
About
Early Therapeutics Development with Phase 2 Emphasis-261017101
University of California Sys Office/Pres, Oakland, CA, United States
Search grants from University of California Sys Office/Pres
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
M. Hong RT&D
Center for Pediatric Research
Genetic and Environmental Causes of Celiac Disease
Quantitative Two Photon Excited Calcium Uncaging
Kansas Idea
Recently added grants:
Evolutionary adaptation and spatial organization of signaling in the Mitotic Exit Network
Behavioral and neural properties of spatial direction comprehension in aging and amestic mild cognitive impairment
Community Paramedicine Program to Improve Diabetes Management among Adults Experiencing Severe Hypoglycemia
Targeting Pannexin 1 as a Novel Mechanism for Arrhythmia and Fibrosis in Duchenne Cardiomyopathy
Examining the Stress Processes Relating Ethnicity and Sex to Substance Misuse and Services Outcomes (ESPRESSO)
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA017101-002
Application #
6688650
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2002
Total Cost
Indirect Cost
Institution
Name
University of California Sys Office/Pres
Department
Type
DUNS #
003985512
City
Oakland
State
CA
Country
United States
Zip Code
94607
Related projects
NIH 2005
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017101
/ University of California Sys Office/Pres
NIH 2004
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017101
/ University of California Sys Office/Pres
NIH 2003
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017101
/ University of California Sys Office/Pres
NIH 2002
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017101
/ University of California Sys Office/Pres
Comments
Be the first to comment on this grant